On Track With Chronic Kidney Disease: The Race to Early Detection and Risk Reduction in Type 1 and Type 2 Diabetes

Details

June 6 @ 6:30 pm 8:00 pm CDT

Sponsored By: Medscape Live Meeting Service, LLC.
Supported By: An independent educational grant from Bayer.

Program Description

Chronic kidney disease (CKD) is a common, underrecognized complication of diabetes that substantially increases cardiovascular risk and worsens long-term outcomes in both type 1 and type 2 diabetes.

Join us for an interactive race-style CME symposium aimed at guiding clinicians through key decision points in early CKD detection, risk stratification, and comprehensive management. Learners will work through evolving patient cases, interpret test results, apply current guideline recommendations, and select evidence-based cardiorenal-protective therapies, with an emphasis on multidisciplinary collaboration to slow CKD progression and reduce cardiovascular (CV) events.

Register now to stay ahead in diabetes-related CKD care.

Speakers

Host

​​Charles P. Vega MD, FAAFP
Clinical Professor of Family Medicine; Associate Dean
School of Medicine
University of California
Director
UC Irvine Program in Medical Education for the Latino Community (PRIME-LC)
Irvine, CA

Chair

Peter Rossing MD, DMSc
Professor
Department of Clinical Medicine
University of Copenhagen
Head of Research

Steno Diabetes Center Copenhagen
Copenhagen, Denmark

Speaker

Janet B. McGill MD, MA, FACE, FACP
Professor of Medicine
Division of Endocrinology, Metabolism, and Lipid Research
​Washington University School of Medicine
St. Louis, MO

Speaker

​​Chantal Mathieu MD, PhD
Professor of Medicine
Katholieke Universiteit Leuven
Professor of Medicine
Department of Endocrinology
University Hospital Gasthuisberg
Leuven, Belgium